M&A Deal Summary |
|
---|---|
Date | 2014-03-20 |
Target | Selah Genomics |
Sector | Healthcare Services |
Buyer(s) | EKF Diagnostics Holdings |
Sellers(s) |
NMT Capital
The BroadOak Fund |
Deal Type | Add-on Acquisition |
Deal Value | 70M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1990 |
Sector | Medical Products |
Employees | 386 |
Revenue | 53M GBP (2023) |
EKF Diagnostics Holdings is a global, integrated medical diagnostics business. EKF designs and manufactures diagnostic equipment for use within point-of-care settings. EKF Diagnostics is also a manufacturer of liquid reagents used in central laboratory analysers and also sells a number of benchtop analyzers. EKF Diagnostics Holdings was incorporated in 1990 and is based in Cardiff, the United Kingdom.
DEAL STATS | # |
---|---|
Overall | 2 of 3 |
Sector (Healthcare Services) | 2 of 2 |
Type (Add-on Acquisition) | 2 of 3 |
State (South Carolina) | 1 of 1 |
Country (United States) | 1 of 2 |
Year (2014) | 2 of 2 |
Size (of disclosed) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-03-20 |
DiaSpect Medical AB
Uppsala, Sweden DiaSpect Medical AB point of Care hemoglobin measurements to primary care anywhere in the world. |
Buy | £21M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-11-12 |
Advanced Diagnostic Laboratory
San Antonio, Texas, United States Advanced Diagnostic Laboratory is a PCR-focused testing laboratory certified under the Clinical Laboratory Improvement Amendments (“CLIA”) for high-complexity molecular diagnostics testing. Advanced Diagnostic Laboratory is based in San Antonio, Texas. |
Buy | - |
Category | Private Equity Firm |
---|---|
Size | Small |
Type | Sector Agnostic |
NMT Capital is a private equity firm focused on tech-oriented growth industries. Areas of interest include medical devices, diagnostics, biotechnology, specialty pharmaceutical, drug discovery tools, software, communications, information technology, and advanced materials. NMT Capital is based in Quincy, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 6 of 10 |
Sector (Healthcare Services) | 2 of 2 |
Type (Add-on Acquisition) | 5 of 9 |
State (South Carolina) | 2 of 2 |
Country (United States) | 4 of 8 |
Year (2014) | 1 of 2 |
Size (of disclosed) | 4 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2012-10-18 |
Presidio Pharmaceuticals
San Francisco, California, United States Presidio Pharmaceuticals is a specialty pharmaceutical company focusing on in-licensing, developing, and commercializing novel and validated therapeutics for chronic viral infections, including HIV-1, HCV, and CMV. Presidio Pharmaceuticals was founded in 2006 and is based in San Francisco, California. |
Sell | $101M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-12-02 |
Mini-Lap Technologies
Dobbs Ferry, New York, United States Minilap is developing and marketing ultra minimally invasive surgical instruments with direct-through-skin capability, eliminating the need to close the puncture and leaving little or no residual scar. Mini-Lap Technologies is based in Dobbs Ferry, New York. |
Sell | - |
The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.
DEAL STATS | # |
---|---|
Overall | 3 of 6 |
Sector (Healthcare Services) | 1 of 1 |
Type (Add-on Acquisition) | 3 of 5 |
State (South Carolina) | 1 of 1 |
Country (United States) | 3 of 6 |
Year (2014) | 2 of 2 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-02-28 |
Aragen Bioscience
Morgan Hill, California, United States Aragen Bioscience, Inc. is a preclinical custom contract research organization that provides in vitro and in vivo research to pharmaceutical, biotechnology and research institutions. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-05-12 |
Diagnostic BioSystems
Pleasanton, California, United States Diagnostic BioSystems is committed to enhancing immunohistochemistry results by providing innovative anatomic pathology reagents and systems to improve the practice of pathology. Since the inception, Its prime focus has been to provide high quality products and exceptional customer service and support. Diagnostic BioSystems was founded in 1994 and is based in Pleasanton, California. |
Buy | - |